Acorah Software Products - Accounts Production 16.7.461 false true false true No description of principal activity 12 June 2024 30 June 2025 30 June 2025 15775104 Miss Tia White iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15775104 2024-06-11 15775104 2025-06-30 15775104 2024-06-12 2025-06-30 15775104 frs-core:CurrentFinancialInstruments 2025-06-30 15775104 frs-bus:PrivateLimitedCompanyLtd 2024-06-12 2025-06-30 15775104 frs-bus:FilletedAccounts 2024-06-12 2025-06-30 15775104 frs-bus:Micro-entities 2024-06-12 2025-06-30 15775104 frs-bus:AuditExempt-NoAccountantsReport 2024-06-12 2025-06-30 15775104 frs-bus:Director1 2024-06-12 2025-06-30
Registered number: 15775104
Amaze Pharma Limited
Unaudited Financial Statements
For the Period 12 June 2024 to 30 June 2025
Amaze Pharma Limited
Balance Sheet
As At 30 June 2025
Balance Sheet
Registered number: 15775104

| 30 June 2025
--- | ---
|  | £
Current assets |  | 9,810
Creditors: Amounts Falling Due Within One Year |  | (6,966 )
NET CURRENT ASSETS |  | 2,844
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 2,844
NET ASSETS |  | 2,844
CAPITAL AND RESERVES |  | 2,844

## Notes

1. General Information
Amaze Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15775104 . The registered office is Belmont Suite Paragon Business Park, Chorley New Road, Bolton, BL6 6HG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Miss Tia White Director
09/01/2026